Elderly individuals face increased thrombosis risk due to aging factors and atherosclerosis. Low-dose aspirin effectively inhibits thromboxane B2, a key factor in platelet aggregation, potentially reducing thrombotic events.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: